Base on the network pharmacology analysis and molecular docking, we found PI3K-Akt pathway is one of the targets of ASD to against the disorders involving impaired neurogenesis, such as Alzheimer’s disease, major depressive disorder and anxiety disorder. Here, AKT1 is linked to Alzheimer disease.